Figure 2.

Patient disposition. ^aOne patient in the high-dose group did not have any postbaseline data and was excluded from the efficacy population. ^bTwo patients in the high-dose hyperglycemia group did not have any postbaseline efficacy data while on study drug and were excluded from the hyperglycemia population.